Abduch MCD, Alencar AM, Mathias Jr. W, Vieira ML de C. Cardiac Mechanics Evaluated by Speckle Tracking Echocardiography. Arquivos Brasileiros de Cardiologia. 2014;
2.
Muiesan ML, Salvetti M, Paini A, Agabiti-Rosei C, Monteduro C, Galbassini G, et al. Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism. Hypertension. 2008;52(3):529–34.
3.
Indra T, Holaj R, Zelinka T, Petrák O, Štrauch B, Rosa J, et al. Left ventricle remodeling in men with moderate to severe volume-dependent hypertension. Journal of the Renin-Angiotensin-Aldosterone System. 2012;13(4):426–34.
4.
Milan A, Magnino C, Fabbri A, Chiarlo M, Bruno G, Losano I, et al. Left Heart Morphology and Function in Primary Aldosteronism. High Blood Pressure & Cardiovascular Prevention. 2012;19(1):11–7.
5.
Nikiforov VS, Nikishchenkova IV. MODERN POSSIBILITIES OF SPECKLE TRACKING ECHOCARDIOGRAPHY IN CLINICAL PRACTICE. Rational Pharmacotherapy in Cardiology. 13(2):248–55.
6.
Lo CI, Lai YH, Wu JJ. Cardiac systolic mechanics in heart failure with preserved ejection fraction: new insights and controversies. Acta Cardiol Sin. 2013;29(6):515–23.
7.
Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2008;93(9):3266–81.
8.
Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2016;101(5):1889–916.
9.
Smiseth OA, Torp H, Opdahl A, Haugaa KH, Urheim S. Myocardial strain imaging: how useful is it in clinical decision making? European Heart Journal. 2016;37(15):1196–207.
10.
Kaplan NM, Victor RG. Primary aldosteronism. 2015.
11.
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal – Cardiovascular Imaging. 2015;16(3):233–71.
12.
Sugimoto T, Dulgheru R, Bernard A, Ilardi F, Contu L, Addetia K, et al. Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study. European Heart Journal - Cardiovascular Imaging. 2017;18(8):833–40.
13.
Warchoł-Celińska E, Lenders JWM, Januszewicz A, Prejbisz A. Cardiovascular Risk in Primary Hyperaldosteronism. Hormone and Metabolic Research. 2015;47(13):973–80.
14.
Luther JM. Aldosterone in vascular and metabolic dysfunction. Current Opinion in Nephrology and Hypertension. 2016;25(1):16–21.
15.
Colussi G, Brosolo G, Novello M, Sechi LA, Catena C. Aldosterone and Left Ventricular Remodeling. Hormone and Metabolic Research. 2015;47(13):981–6.
16.
Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. Journal of the American College of Cardiology. 2017;69(14):1811–20.
17.
Vatutin NT, Shevelek AN, Degtyareva AE, Kasem SS. Rol’ hiperaldosteronizma i perspektivy primenenia antagonistov al’dosterona pri rezistentnoi arterial’no i hipertenzii (obzorliteratyru) [The role of hyperaldosteronism and the prospects for using of aldosterone antagonists in resistant hypertension (literature review. Zhurnal Natsional’noi akademii meduchnukh nauk. 2014;20(1):43–51.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
